Konturek S J, Tasler J, Mikos E, Jaeger E, Wünsch E
Hepatogastroenterology. 1980 Feb;27(1):35-40.
Three synthetic preparations of big gastrin (G-34), little gastrin (G-17) and minigastrin (G-14) have been compared with regard to gastric acid stimulatory potency, rate of disappearance and the relation between acid secretion and the change in serum immunoreactive gastrin in gastric fistula and Heidenhain pouch dogs. Equimolar graded doses (12.5 to 200 pmol/kg-hr) of G-14, G-17 and G-34 produced similar rates of acid secretion with equal ED50 for all three gastrin peptides. Equimolar doses of G-14 and G-17 also resulted in similar increments in serum immunoreactive gastrin, but those of G-34 caused approximately two to three times greater increments in serum gastrin than did G-14 or G-17. The disappearance half-times determined by measuring serum gastrin at short intervals after discontinuation of equimolar dose (1000 pmol/kg-hr) infusions of each gastrin peptide were 1.75, 4.85 and 11.53 min for G-14, G-17 and G-34, respectively. The calculated space of distribution was similar for all three gastrin preparations and ranged from 20-30% body weight. These results indicate that the three major gastrin components differ in half-times and in relating secretory potency, in that relatively higher molar concentrations of G-34 than G-14 or G-17 were required to produce equal rates of acid secretion.
对三种合成的大胃泌素(G-34)、小胃泌素(G-17)和微小胃泌素(G-14)制剂进行了比较,比较内容包括胃酸刺激效力、消失速率以及胃瘘和海登海因小胃犬胃酸分泌与血清免疫反应性胃泌素变化之间的关系。G-14、G-17和G-34的等摩尔分级剂量(12.5至200 pmol/kg·小时)产生相似的胃酸分泌速率,三种胃泌素肽的半数有效剂量(ED50)相等。G-14和G-17的等摩尔剂量也导致血清免疫反应性胃泌素出现相似的增量,但G-34的等摩尔剂量导致血清胃泌素的增量比G-14或G-17大约高两到三倍。在停止输注每种胃泌素肽的等摩尔剂量(1000 pmol/kg·小时)后,通过短时间间隔测量血清胃泌素确定的G-14、G-17和G-34的消失半衰期分别为1.75、4.85和11.53分钟。三种胃泌素制剂的计算分布空间相似,范围为体重的20%-30%。这些结果表明,三种主要胃泌素成分在半衰期和分泌效力方面存在差异,即产生相等胃酸分泌速率所需的G-34的摩尔浓度相对高于G-14或G-17。